Search Within

Joachim Yahalom

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (31)
  2. Journal Article (22)
  3. Research Letter (2)
Groups
  1. Molecular Imaging and Therapy Service (55)
  2. Radiation Oncology, Department of (55)
  3. Radiology, Department of (55)
  4. Survivorship Research (55)
  5. Department of Medicine (48)
  6. Center for Hematologic Malignancies (47)

More Groups

People
  1. Heiko Schoder (50)
  2. Maria Palomba (36)
  3. Ariela Noy (35)
  4. Alison Moskowitz (33)
  5. Andrew Zelenetz (33)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Blood (21)
  2. Hematological Oncology (6)
  3. International Journal of Radiation Oncology, Biology, Physics (6)
  4. Journal of Clinical Oncology (4)
  5. Blood Advances (2)
  6. Blood Cancer Journal (2)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. Elsevier Inc. (8)
  3. Wiley Blackwell (7)
  4. American Society of Clinical Oncology (4)
  5. Ferrata Storti Foundation (2)
  6. Nature Publishing Group (2)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metabolic tumor volume and total lesion glycolysis can predict response to very low dose radiotherapy (4 Gy) in indolent B-cell lymphomas
    Meeting Abstract

    Wijetunga, N. A.; Imber, B. S.; Lee, J.; Hajj, C.; Mayerhoefer, M. E.; Schoder, H.; Yahalom, J.
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rosai-Dorfman disease - Utility of (18)F-FDG PET/CT for initial evaluation and follow-up
    Journal Article

    Mahajan, S.; Nakajima, R.; Yabe, M.; Dogan, A.; Ulaner, G. A.; Yahalom, J.; Noy, A.; Diamond, E. L.; Schöder, H.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Long-term follow-up confirms durability of single-agent brentuximab vedotin as pre-transplant salvage for classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Schoder, H.; Lee, J.; Davey, T.; Hancock, H.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; Noy, A.; more...
    Blood (2019)

    Fulltext@MSK | Save